Industry payments to hospitalist physicians: a 5-year analysis of the Open Payments programme from 2014 to 2018.

Autor: Pakanati KC; Department of Internal Medicine, Envision Physician Services, Plantation, Florida, USA., Siddamreddy S; Department of Internal Medicine, Baptist Health Program, North Little Rock, Arkansas, USA., Nalleballe K; Department of Neurology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Thombre V; Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Sheng S; Department of Neurology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Veerapaneni K; Department of Neurology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Yadala S; Department of Neurology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Kapoor N; Department of Neurology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA., Dandu V; Department of Internal Medicine, Baptist Health Program, North Little Rock, Arkansas, USA., Avula A; Department of Internal Medicine, Staten Island University Hospital, Staten Island, New York, USA., Meegada S; Department of Internal Medicine, UT Health Science Center, Longview, Texas, USA., Bere P; Department of Internal Medicine, Desert Regional Medical Center, Palm Springs, California, USA.
Jazyk: angličtina
Zdroj: Internal medicine journal [Intern Med J] 2020 Dec; Vol. 50 (12), pp. 1547-1550.
DOI: 10.1111/imj.15116
Abstrakt: We analysed Open Payments programme data (https://openpaymentsdata.cms.gov) on industry-to-physician payments to hospitalists for the years 2014 to 2018. Payments to hospitalists increased by 106.5% from 2014 to 2018 with food and beverage (38.5%) and compensation for services other than consulting (24.3%) being the highest-paid categories. Industry payment to hospitalists was highly skewed with top 10 hospitalists receiving more than 30% of the total payments during the study period. The most common drugs associated with payments were anticoagulant medications (apixaban and rivaroxaban). Industry seems to be spending a significant amount of money to increase awareness of medications among hospitalists. Identification of these trends and potential motives of industry spending is critical to address any potential physician bias.
(© 2020 Royal Australasian College of Physicians.)
Databáze: MEDLINE
Externí odkaz: